Optomap provides a detailed evaluation of the retina without dilation to help the eye doctor detect early signs of conditions like cancer, diabetes, stroke, and cardiovascular disease.
A powerful clinical tool that transforms the way we assess the retina, optic disc and the cornea, and further quantify the thickness of the retina, nerve fiber layer, ganglion cell complex and the cornea to aid in disease diagnosis. |
The only FDA 510(k) cleared, non-mydriatic, full-field mobile ERG device. This technology allows for the assessment and diagnoses of diabetic retinopathy, glaucoma, pediatric nystagmus, and acquired and inherited retinal diseases, as well as quantify changes in color vision measured by extended color vision diagnostics. |
|
|